Cell Signaling Technology (United States)
Cell Signaling Technology, Inc. is a privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Cell Signaling Technology (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
68%
Total
Publications
519
Total Open
Publications
355
Total
Citations
69K
Open Access
Percentage
68%
Total
Publications
519
Total Open
Publications
355
Total
Citations
69K
Breakdown
Publisher Open
19%
Both
33%
Other Platform Open
13%
Closed
35%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 52%
129
Hybrid 17%
43
No Guarantees 31%
77
Other Platform Open
Domain 69%
161
Other Internet 25%
58
Institution 14%
32
Public 6%
13
Preprint 0%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 161 |
DOI | Other Internet | 57 |
Figshare | Public | 13 |
DASH - Digital Access to Scholarship at Harvard | Institution | 11 |
Europe PMC | Domain | 7 |
Massachusetts Institute of Technology - DSpace@MIT | Institution | 4 |
University of Turin - Institutional Research Information System University of Turin | Institution | 3 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 3 |
DANS - Data Archiving and Networked Services | Institution | 3 |
Yonsei University Medical Library - YUHSpace | Institution | 2 |